GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
A New Era in Alzheimer's Research: Moving Beyond Amyloid
For decades, the public conversation surrounding Alzheimer’s disease focused almost exclusively on a single culprit: sticky protein deposits in the brain known as amyloid-beta plaques. The dominant theory held that if medicine could simply scrub these plaques away, memory loss and cognitive decline could be halted.
Beyond Plaques & Tangles: The Brand-New Genomic & Micro-Wiring Discoveries Reshaping Alzheimer’s
Explore brand-new September 2026 breakthroughs in Alzheimer's research, from Salk's hidden microproteins to 3D genome folding and protective brain wiring.